EPB0189 Reversibility of neuropsychiatric adverse events after switching to Darunavir/cobicistat or Doravirine in men on INSTI based regimenE-posterClinical complications of HIV and antiretroviral therapy
EPC0337 Retrospective cohort study of factors associated with non-initiation of antiretroviral therapy among adults newly diagnosed with HIV in Andijan, Uzbekistan, 2018-2021E-posterSurveillance: Measuring the HIV epidemic
EPE0805 Rethinking DREAMS completion: comparison of approaches in the Zimbabwean contextE-posterImplementation science and scale up of prevention
EPE0767 Retesting for HIV among individuals on ART during community-based distribution of HIV self-tests – a mixed-methods study in rural ZimbabweE-posterImplementation science and scale up of HIV testing
LBEPC29 Retention and clinical outcomes improve after implementation of test and treat policy among children living with HIV in Zambia: a retrospective cohort studyE-posterCascades of HIV care and treatment
EPE0796 Results of the end-line evaluation of a PrEP demonstration project among MSM and TGW in MyanmarE-posterImplementation science and scale up of prevention
TUPEB18 Resistance to second generation integrase inhibitors after two years of a national rollout strategy in MexicoPoster exhibitionART resistance
OAA0102 Resident microbiota enhance HIV acquisition, replication, and pathogenesis in vivoOral abstract session with live Q&AHIV pathogenesis
TUPEE11 Reproductive coercion, viral suppression, and integrated sexual and reproductive health services among women living with HIV in 11 countriesPoster exhibitionHIV and development synergies
OAD0102 Reporting, prevention and response of gender based violence against men who have sex with men in Taraba State, NigeriaOral abstract session with live Q&ASocial and behavioural aspects and approaches to HIV
291 - 300 of 1427 items